Verified Nov 2026
Other
·

Woodcliff Lake, New Jersey
·
Since 2007
Eagle Pharmaceuticals is a specialty pharmaceutical company headquartered in Woodcliff Lake, New Jersey, founded in 2007. The company employs 100-200 people and generates an estimated $250-500 million in annual revenue. It develops and commercializes injectable products for oncology, critical care, and orphan diseases using the FDA's 505(b)(2) regulatory pathway. The company's approved medications include PEMFEXY® for lung cancer, RYANODEX® for heatstroke, and BENDEKA® for chronic lymphocytic leukemia.
Eagle Pharmaceuticals, Inc. at a glance
Revenue
$250-500M
Est. band
Employees
100-200
Founded
2007
Headquarters
Woodcliff Lake, New Jersey
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Eagle Pharmaceuticals is a specialty pharmaceutical company headquartered in Woodcliff Lake, New Jersey, founded in 2007. The company employs 100-200 people and generates an estimated $250-500 million in annual revenue. It develops and commercializes injectable products for oncology, critical care, and orphan diseases using the FDA's 505(b)(2) regulatory pathway. The company's approved medications include PEMFEXY® for lung cancer, RYANODEX® for heatstroke, and BENDEKA® for chronic lymphocytic leukemia.
At a glance
Attribute | Detail |
|---|---|
Founded | 2007 |
Headquarters | Woodcliff Lake, New Jersey |
Employees | 100-200 |
Revenue | $250-500M (estimated) |
What Eagle Pharmaceuticals, Inc. makes
The company maintains research facilities in Massachusetts and regional offices in Florida and Indiana, developing a pipeline of injectable candidates for conditions including breast cancer and severe bacterial pneumonia.
Products and capabilities described on the company's own site include Valve (source: eagleus.com).
Latest developments
2026-01-14 — Eagle Pharmaceuticals Announces Divestiture of Barhemsys (globenewswire.com)
2025-10-30 — Eagle Pharmaceuticals Board Extends Limited Duration (globenewswire.com)
2025-08-28 — Eagle Pharmaceuticals’ Cooperation Agreement With Nantahala Capital Management // Cooley // Global Law Firm (cooley.com)
2025-07-02 — EAGLE ROYALTIES AND SUMMIT ROYALTY EXECUTE ... (newswire.ca)
2025-04-01 — Latham Watkins Advises Eagle Pharmaceuticals in Royalty Monetization With Blue Owl Capital (lw.com)
2025-03-31 — Eagle Pharmaceuticals Announces $69 Million Agreement to (globenewswire.com)
Company details
Eagle Pharmaceuticals executed a royalty monetization agreement with Blue Owl Capital in April 2025 to optimize its capital structure. Eagle Pharmaceuticals, Inc. was founded in 2007, has an estimated 100-200 employees, and is headquartered in Woodcliff Lake, New Jersey.
Frequently asked questions
What does Eagle Pharmaceuticals, Inc. do?
Eagle Pharmaceuticals is a specialty pharmaceutical company headquartered in Woodcliff Lake, New Jersey, founded in 2007. The company employs 100-200 people and generates an estimated $250-500 million in annual revenue. It develops and commercializes injectable products for oncology, critical care, and orphan diseases using the FDA's 505(b)(2) regulatory pathway. The company's approved medications include PEMFEXY® for lung cancer, RYANODEX® for heatstroke, and BENDEKA® for chronic lymphocytic leukemia.
Where is Eagle Pharmaceuticals, Inc. headquartered?
Eagle Pharmaceuticals, Inc. is headquartered in Woodcliff Lake, New Jersey (50 Tice Boulevard, Woodcliff Lake, New Jersey, 07677).
When was Eagle Pharmaceuticals, Inc. founded?
Eagle Pharmaceuticals, Inc. was founded in 2007.
How big is Eagle Pharmaceuticals, Inc.?
Eagle Pharmaceuticals, Inc. has an estimated 100-200 employees, with revenue in the $250-500M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
